Inventor · disambiguated record
Matthias Lechmann
Also filed as: LECHMANN MATTHIAS
6 granted patents·21 citations·filing 2002–2014
78Inventor score
Top patents by PatentIndex Score
6 records- 0183US7169898B2Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cellsSTEINKASSERER ALEXANDER·Filed 2002·Granted Jan 30, 2007·13 cites·2 claims
- 0277US8124099B2Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cellsSTEINKASSERER ALEXANDER·Filed 2007·Granted Feb 28, 2012·3 cites·8 claims
- 0371US8759505B2Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseasesSTEINKASSERER ALEXANDER·Filed 2011·Granted Jun 24, 2014·2 cites·19 claims
- 0462US7893200B2Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseasesARGOS THERAPEUTICS INC·Filed 2003·Granted Feb 22, 2011·3 cites·13 claims
- 0557US9732140B2Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseasesARGOS THERAPEUTICS INC·Filed 2014·Granted Aug 15, 2017·0 cites·10 claims
- 0647US9102726B2Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing sameSTEINKASSERER ALEXANDER·Filed 2003·Granted Aug 11, 2015·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →